UK Startup Backed by Patrick Collison Exits Stealth to Generate Drug Discovery Data From Physics
Reported by Tech Times1 source ↓
Cambridge-based Potential Sciences has exited stealth with an eight-figure seed round backed by the UK’s Sovereign AI fund and Patrick Collison. It is developing GPU-based quantum chemistry to generate molecular data for drug-discovery AI.
Key points
- The round also includes seed investor Twin Path Ventures; its exact size was not disclosed
- The company says its system can run calculations at about one-hundredth the cost of CPU-based equivalents
- Potential Sciences will access the UK’s Isambard-AI supercomputer through the Sovereign AI investment
- The cost claim has not been independently audited
Details
Tech Times reports that Potential Sciences is registered in London and operates from Cambridge. The company was incorporated less than a year before its November 6, 2026, stealth exit. Its backers include the UK government’s £500 million Sovereign AI fund, seed investor Twin Path Ventures and Stripe co-founder Patrick Collison; the article does not state the round’s exact size.
Potential Sciences says it has rebuilt density functional theory, a quantum chemistry method, for GPUs. The company’s aim is to use the hardware to generate data about molecules that have not been experimentally tested, addressing what it describes as a shortage of training data for drug-discovery AI.
The company claims its calculations cost about one-hundredth as much as equivalent calculations on CPU infrastructure, but Tech Times reports that this figure has not been independently audited. The startup is due to access the UK’s Isambard-AI supercomputer through the Sovereign AI investment.
Written from coverage as of
Images
- Tech Times